|Articles|September 24, 2010

Medical Economics, Digital Edition, September 24th, 2010

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, September 24th, 2010

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

New Medicare ACCESS model aims to reward results, not volume, for chronic disease care

Saving America's primary care system requires bold action now

10 ways AI is creeping into medical care

59% of health care workers plan to look for a new job in the next year, Harris Poll finds

New partnerships or fragmented care? A primary care leader discusses Medicare’s ACCESS model